Calamos Wealth Management LLC Invests $301,000 in Humana Inc. $HUM

Calamos Wealth Management LLC acquired a new stake in Humana Inc. (NYSE:HUM) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,735 shares of the insurance provider’s stock, valued at approximately $301,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after purchasing an additional 106,030 shares during the period. Capital International Investors boosted its holdings in Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of Humana by 34.3% in the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after buying an additional 1,398,774 shares during the period. State Street Corp grew its stake in shares of Humana by 1.8% in the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after buying an additional 97,211 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Humana by 28.9% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after buying an additional 1,008,514 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently commented on HUM. Bank of America lifted their price target on shares of Humana from $340.00 to $380.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Zacks Research raised Humana from a “hold” rating to a “strong-buy” rating in a research note on Monday. Needham & Company LLC assumed coverage on Humana in a research report on Wednesday, May 20th. They issued a “buy” rating on the stock. Mizuho upped their price target on Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Finally, Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fifteen have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $325.87.

Humana Stock Performance

NYSE:HUM opened at $406.98 on Thursday. The company has a fifty day simple moving average of $348.73 and a two-hundred day simple moving average of $258.30. The company has a market cap of $48.86 billion, a price-to-earnings ratio of 43.53, a price-to-earnings-growth ratio of 2.32 and a beta of 0.71. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $415.00.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same period last year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana News Roundup

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Zacks Research upgraded Humana (HUM) to strong-buy, signaling improved analyst confidence in the insurer’s outlook. Zacks upgrade report
• Positive Sentiment: Zacks Research raised earnings estimates across several periods, including FY2026 EPS to $9.04 and FY2027 EPS to $13.30, reinforcing the view that Humana’s earnings may improve materially over the next few years.
• Positive Sentiment: Truist Financial increased its price target on Humana to $415, close to the stock’s recent trading range, which can help validate the current rally. Truist price target raise
• Neutral Sentiment: Investors are also weighing commentary about whether Humana is already fully valued after its recent run, which may limit upside unless upcoming results confirm the improved earnings outlook. Yahoo Finance valuation article
• Neutral Sentiment: One article argues that Humana’s Q2 earnings need to catch up with the stock’s performance, meaning the market may be awaiting confirmation from the upcoming report before pushing the shares much higher. Seeking Alpha article
• Negative Sentiment: News that Humana’s agreement with Wexner Medical Center is set to end in October, and another report that its insurance network is terminating an agreement with Ohio State, could raise concerns about network disruption or member retention. Wexner Medical Center agreement article

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.